Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of GPR55 attenuates cognitive impairment and neurotoxicity in a mouse model of Alzheimer's disease induced by Aβ1–42 through inhibiting RhoA/ROCK2 pathway
XiaoTong Xiang, Xin Wang, Shiyu Jin, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 112, pp. 110423-110423
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives
Xiuli Wang, Huanbang Zhang, Yan Liu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106810-106810
Closed Access | Times Cited: 26
Comprehensive Overview of Alzheimer’s Disease: Etiological Insights and Degradation Strategies
Manish Kumar Singh, Yoonhwa Shin, Songhyun Ju, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6901-6901
Open Access | Times Cited: 12
Injection of amyloid-β to lateral ventricle induces gut microbiota dysbiosis in association with inhibition of cholinergic anti-inflammatory pathways in Alzheimer’s disease
Xiaohang Qian, Xiaoli Liu, Guang Chen, et al.
Journal of Neuroinflammation (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology
Monika Kadian, Neetu Saini, Alka Khera, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1545-1573
Closed Access | Times Cited: 5
The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling
Argelia Calvillo-Robledo, Rodolfo Daniel Cervantes‐Villagrana, Paula Morales, et al.
Life Sciences (2022) Vol. 301, pp. 120596-120596
Open Access | Times Cited: 19
The Expression of the Endocannabinoid Receptors CB2 and GPR55 is Highly Increased during the Progression of Alzheimer’s Disease in AppNL-G-F Knock-In Mice
Dina Medina‐Vera, Hongjing Zhao, Erika Bereczki, et al.
Biology (2023) Vol. 12, Iss. 6, pp. 805-805
Open Access | Times Cited: 12
Review of PINK1-Parkin-mediated mitochondrial autophagy in Alzheimer's disease
Ting-Yuan Zhou, Ruixia Ma, Jia Li, et al.
European Journal of Pharmacology (2023) Vol. 959, pp. 176057-176057
Closed Access | Times Cited: 11
Modulation of neuroinflammation and oxidative stress by targeting GPR55 – new approaches in the treatment of psychiatric disorders
Matthias Apweiler, Soraya Wilke Saliba, Lu Sun, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 12, pp. 3779-3788
Open Access | Times Cited: 4
Modulations of bioactive lipids and their receptors in postmortem Alzheimer’s disease brains
Makoto Kurano, Yuko Saito, Baasanjav Uranbileg, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 17
Inhibition of GPR17 with cangrelor improves cognitive impairment and synaptic deficits induced by Aβ1–42 through Nrf2/HO-1 and NF-κB signaling pathway in mice
Shiyu Jin, Xin Wang, XiaoTong Xiang, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108335-108335
Closed Access | Times Cited: 19
Inhibiting microRNA-142–5p improves learning and memory in Alzheimer’s disease rats via targeted regulation of the PTPN1-mediated Akt pathway
Weiwei Liang, Zhuojun Xie, Dong Liao, et al.
Brain Research Bulletin (2022) Vol. 192, pp. 107-114
Open Access | Times Cited: 13
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis
Sonia Burgaz, Concepción García, Claudia Gonzalo‐Consuegra, et al.
Molecules (2021) Vol. 26, Iss. 24, pp. 7643-7643
Open Access | Times Cited: 15
Pharmacological Activation of GPR55 Improved Cognitive Impairment Induced by Lipopolysaccharide in Mice
Xin Wang, XiaoTong Xiang, Jie Hu, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 8, pp. 1656-1669
Closed Access | Times Cited: 11
Inhibition of RhoA/ROCK signalling pathway activity improves neural damage and cognitive deficits in the fluorosis model
Chen Lingli, Hong‐Mei Ning, Jia Penghuan, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 266, pp. 115554-115554
Open Access | Times Cited: 5
ROCK and PDE-5 Inhibitors for the Treatment of Dementia: Literature Review and Meta-Analysis
Dong-Hun Lee, Ji Young Lee, Dong-Yong Hong, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1348-1348
Open Access | Times Cited: 8
Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer’s Disease
Yueh‐Ting Tsai, Shung‐Te Kao, Chin‐Yi Cheng
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11311-11311
Open Access | Times Cited: 8
A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease Across a Decade of Research
Petros Tyrakis, Christina Agridi, Malamati Kourti
(2024)
Open Access | Times Cited: 1
Cannabinoids’ Role in Modulating Central and Peripheral Immunity in Neurodegenerative Diseases
Nitzan Sharon, Ludmila Yarmolinsky, Boris Khalfin, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6402-6402
Open Access | Times Cited: 1
A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer’s Disease across a Decade of Research
Petros Tyrakis, Christina Agridi, Malamati Kourti
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8630-8630
Open Access | Times Cited: 1
Investigating causality and shared genetic architecture between body mass index and cognitive function: a genome-wide cross-trait analysis and bi-directional Mendelian randomization study
Mingyi Chen, Xiaoxin Xu, Fang Wang, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 1
An In Silico Study for Expanding the Utility of Cannabidiol in Alzheimer’s Disease Therapeutic Development
Kyudam Choi, Yurim Lee, Cheongwon Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 16013-16013
Open Access | Times Cited: 3
Deletion of MyD88 in astrocytes prevents β‐amyloid‐induced neuropathology in mice
Tee Jong Huat, Tessa Onraet, Judith Camats‐Perna, et al.
Glia (2022) Vol. 71, Iss. 2, pp. 431-449
Open Access | Times Cited: 5
Activation of GPR55 Ameliorates Maternal Separation-Induced Learning and Memory Deficits by Augmenting 5-HT Synthesis in the Dorsal Raphe Nucleus of Juvenile Mice
Ting Sun, Ya-Ya Du, Yongqiang Zhang, et al.
ACS Omega (2024)
Open Access
Hippocampal GPR35 Participates in the Pathogenesis of Cognitive Deficits and Emotional Alterations Induced by Aβ1–42 in Mice
Yusheng Liang, Yan Yang, Zhi Jie, et al.
Molecular Neurobiology (2024)
Closed Access
Black Soybean Peptides Target the Rock/Mapk Signaling Pathway to Ameliorate Lead-Induced Oxidative Stress in Ht22 Cells
Huijie Yang, Fangyu Wang, Tiange Li, et al.
(2024)
Closed Access
Page 1 - Next Page

Scroll to top